Literature DB >> 25206287

Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests.

Vicente Felipo1, Amparo Urios1, Carla Giménez-Garzó1, Omar Cauli1, Maria-Jesús Andrés-Costa1, Olga González1, Miguel A Serra1, Javier Sánchez-González1, Roberto Aliaga1, Remedios Giner-Durán1, Vicente Belloch1, Carmina Montoliu1.   

Abstract

AIM: To assess whether non invasive blood flow measurement by arterial spin labeling in several brain regions detects minimal hepatic encephalopathy.
METHODS: Blood flow (BF) was analyzed by arterial spin labeling (ASL) in different brain areas of 14 controls, 24 cirrhotic patients without and 16 cirrhotic patients with minimal hepatic encephalopathy (MHE). Images were collected using a 3 Tesla MR scanner (Achieva 3T-TX, Philips, Netherlands). Pulsed ASL was performed. Patients showing MHE were detected using the battery Psychometric Hepatic Encephalopathy Score (PHES) consisting of five tests. Different cognitive and motor functions were also assessed: alterations in selective attention were evaluated using the Stroop test. Patients and controls also performed visuo-motor and bimanual coordination tests. Several biochemical parameters were measured: serum pro-inflammatory interleukins (IL-6 and IL-18), 3-nitrotyrosine, cGMP and nitrates+nitrites in plasma, and blood ammonia. Bivariate correlations were evaluated.
RESULTS: In patients with MHE, BF was increased in cerebellar hemisphere (P = 0.03) and vermis (P = 0.012) and reduced in occipital lobe (P = 0.017). BF in cerebellar hemisphere was also increased in patients without MHE (P = 0.02). Bimanual coordination was impaired in patients without MHE (P = 0.05) and much more in patients with MHE (P < 0.0001). Visuo-motor coordination was impaired only in patients with MHE (P < 0.0001). Attention was slightly affected in patients without MHE and more strongly in patients with MHE (P < 0.0001). BF in cerebellar hemisphere and vermis correlated with performance in most tests of PHES [(number connection tests A (NCT-A), B (NCT-B)and line tracing test] and in the congruent task of Stroop test. BF in frontal lobe correlated with NCT-A. Performance in bimanual and visuomotor coordination tests correlated only with BF in cerebellar hemisphere. BF in occipital lobe correlates with performance in the PHES battery and with CFF. BF in cerebellar hemisphere correlates with plasma cGMP and nitric oxide (NO) metabolites. BF in vermis cerebellar also correlates with NO metabolites and with 3-nitrotyrosine. IL-18 in plasma correlates with BF in thalamus and occipital lobe.
CONCLUSION: Non invasive BF determination in cerebellum using ASL may detect MHE earlier than the PHES. Altered NO-cGMP pathway seems to be associated to altered BF in cerebellum.

Entities:  

Keywords:  Arterial spin labelling; Blood flow; Cerebellum; Minimal hepatic encephalopathy; Neurological impairment

Mesh:

Substances:

Year:  2014        PMID: 25206287      PMCID: PMC4155373          DOI: 10.3748/wjg.v20.i33.11815

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

1.  Arterial spin labeling in combination with a look-locker sampling strategy: inflow turbo-sampling EPI-FAIR (ITS-FAIR).

Authors:  M Günther; M Bock; L R Schad
Journal:  Magn Reson Med       Date:  2001-11       Impact factor: 4.668

2.  Altered modulation of soluble guanylate cyclase in lymphocytes from patients with liver disease.

Authors:  Regina Corbalán; María-Dolores Miñana; Juan A Del Olmo; Miguel A Serra; José M Rodrigo; Vicente Felipo
Journal:  J Mol Med (Berl)       Date:  2001-10-27       Impact factor: 4.599

3.  Cerebellar and premotor function in bimanual coordination: parametric neural responses to spatiotemporal complexity and cycling frequency.

Authors:  F Debaere; N Wenderoth; S Sunaert; P Van Hecke; S P Swinnen
Journal:  Neuroimage       Date:  2004-04       Impact factor: 6.556

4.  Trail Making Test A and B: normative data stratified by age and education.

Authors:  Tom N Tombaugh
Journal:  Arch Clin Neuropsychol       Date:  2004-03       Impact factor: 2.813

5.  Cerebellar cognitive affective syndrome in Machado Joseph disease: core clinical features.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Helena Alessi; Lívia Almeida Dutra; André Carvalho Felício; Thaís Minett; Patrícia Weisman; Ruth F Santos-Galduroz; Paulo Henrique F Bertolucci; Alberto Alain Gabbai; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

6.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

7.  Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.

Authors:  Marta Encinas; Ramón De Juan; Alberto Marcos; Pedro Gil; Ana Barabash; Cristina Fernández; Carmen De Ugarte; José Antonio Cabranes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-15       Impact factor: 9.236

8.  Neuronal nitric oxide has a role as a perfusion regulator and a synaptic modulator in cerebellum but not in neocortex during somatosensory stimulation--an animal PET study.

Authors:  Takuya Hayashi; Yukinori Katsumi; Takahiro Mukai; Manabu Inoue; Yasuhiro Nagahama; Chisako Oyanagi; Hiroshi Yamauchi; Hiroshi Shibasaki; Hidenao Fukuyama
Journal:  Neurosci Res       Date:  2002-10       Impact factor: 3.304

9.  Region selective alterations of soluble guanylate cyclase content and modulation in brain of cirrhotic patients.

Authors:  Regina Corbalán; Nicolas Chatauret; Sönke Behrends; Roger F Butterworth; Vicente Felipo
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 10.  Nitric oxide and its role in ischaemic brain injury.

Authors:  Robert G Keynes; John Garthwaite
Journal:  Curr Mol Med       Date:  2004-03       Impact factor: 2.222

View more
  17 in total

Review 1.  Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment.

Authors:  Ming Luo; Ping Ma; Lei Li; Wu-Kui Cao
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

2.  Current state of knowledge of hepatic encephalopathy (part II): changes in brain white matter tracts integrity are associated with cognitive deficits in minimal hepatic encephalopathy.

Authors:  Carmina Montoliu; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2016-09-20       Impact factor: 3.584

Review 3.  Multimodal MR imaging in hepatic encephalopathy: state of the art.

Authors:  Xiao Dong Zhang; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2018-01-26       Impact factor: 3.584

4.  Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.

Authors:  Jasmohan S Bajaj; Andrew Fagan; Melanie B White; James B Wade; Phillip B Hylemon; Douglas M Heuman; Michael Fuchs; Binu V John; Chathur Acharya; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Am J Gastroenterol       Date:  2019-07       Impact factor: 10.864

5.  Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy.

Authors:  Gang Zheng; Hanzhang Lu; Wenkui Yu; Song Luo; Ya Liu; Wei Liu; Hui Liu; Long Wu; Lijuan Zheng; Xiang Kong; Long Jiang Zhang; Guang Ming Lu
Journal:  Eur Radiol       Date:  2017-05-18       Impact factor: 5.315

6.  A multi-omic study for uncovering molecular mechanisms associated with hyperammonemia-induced cerebellar function impairment in rats.

Authors:  Sonia Tarazona; Héctor Carmona; Ana Conesa; Marta Llansola; Vicente Felipo
Journal:  Cell Biol Toxicol       Date:  2021-01-06       Impact factor: 6.691

7.  The Cerebellum of Patients with Steatohepatitis Shows Lymphocyte Infiltration, Microglial Activation and Loss of Purkinje and Granular Neurons.

Authors:  Tiziano Balzano; Jerónimo Forteza; Pilar Molina; Juan Giner; Ana Monzó; Jennifer Sancho-Jiménez; Amparo Urios; Carmina Montoliu; Vicente Felipo
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

8.  The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients.

Authors:  Carla Giménez-Garzó; Juan José Garcés; Amparo Urios; Alba Mangas-Losada; Raquel García-García; Olga González-López; Remedios Giner-Durán; Desamparados Escudero-García; Miguel Angel Serra; Emilio Soria; Vicente Felipo; Carmina Montoliu
Journal:  PLoS One       Date:  2017-02-01       Impact factor: 3.240

9.  Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in rats with hepatic encephalopathy.

Authors:  Sherry Dadsetan; Tiziano Balzano; Jerónimo Forteza; Ana Agusti; Andrea Cabrera-Pastor; Lucas Taoro-Gonzalez; Vicente Hernandez-Rabaza; Belen Gomez-Gimenez; Nisrin ElMlili; Marta Llansola; Vicente Felipo
Journal:  J Neuroinflammation       Date:  2016-09-13       Impact factor: 8.322

10.  Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy.

Authors:  Raquel García-García; Álvaro Javier Cruz-Gómez; Alba Mangas-Losada; Amparo Urios; Cristina Forn; Desamparados Escudero-García; Elena Kosenko; Juan Fermín Ordoño; Joan Tosca; Remedios Giner-Durán; Miguel Angel Serra; César Avila; Vicente Belloch; Vicente Felipo; Carmina Montoliu
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.